These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

319 related items for PubMed ID: 12038787

  • 1. Long-term persistence of anti-factor VIII antibody-secreting cells in hemophilic mice after treatment with human factor VIII.
    Hausl C, Maier E, Schwarz HP, Ahmad RU, Turecek PL, Dorner F, Reipert BM.
    Thromb Haemost; 2002 May; 87(5):840-5. PubMed ID: 12038787
    [Abstract] [Full Text] [Related]

  • 2. Blockade of CD40/CD40 ligand interactions prevents induction of factor VIII inhibitors in hemophilic mice but does not induce lasting immune tolerance.
    Reipert BM, Sasgary M, Ahmad RU, Auer W, Turecek PL, Schwarz HP.
    Thromb Haemost; 2001 Dec; 86(6):1345-52. PubMed ID: 11776297
    [Abstract] [Full Text] [Related]

  • 3. Single cell analysis of factor VIII-specific T cells in hemophilic mice after treatment with human factor VIII.
    Sasgary M, Ahmad RU, Schwarz HP, Turecek PL, Reipert BM.
    Thromb Haemost; 2002 Feb; 87(2):266-72. PubMed ID: 11858486
    [Abstract] [Full Text] [Related]

  • 4. Deletion or inhibition of Fc gamma receptor 2B (CD32) prevents FVIII-specific activation of memory B cells in vitro.
    Werwitzke S, Vollack N, von Hornung M, Kalippke K, Kutzschbach J, Trummer A, Ganser A, Tiede A.
    Thromb Haemost; 2015 Nov 25; 114(6):1127-35. PubMed ID: 26245154
    [Abstract] [Full Text] [Related]

  • 5. Immunoglobulin isotypes and functional anti-FVIII antibodies in response to FVIII treatment in Balb/c and C57BL/6 haemophilia A mice.
    Qadura M, Waters B, Burnett E, Chegeni R, Hough C, Othman M, Lillicrap D.
    Haemophilia; 2011 Mar 25; 17(2):288-95. PubMed ID: 21091850
    [Abstract] [Full Text] [Related]

  • 6. Mechanism of the immune response to human factor VIII in murine hemophilia A.
    Wu H, Reding M, Qian J, Okita DK, Parker E, Lollar P, Hoyer LW, Conti-Fine BM.
    Thromb Haemost; 2001 Jan 25; 85(1):125-33. PubMed ID: 11204564
    [Abstract] [Full Text] [Related]

  • 7. Characterization of antibodies induced by human factor VIII in a murine knockout model of hemophilia A.
    Reipert BM, Ahmad RU, Turecek PL, Schwarz HP.
    Thromb Haemost; 2000 Nov 25; 84(5):826-32. PubMed ID: 11127864
    [Abstract] [Full Text] [Related]

  • 8. IgG subclasses of anti-FVIII antibodies during immune tolerance induction in patients with hemophilia A.
    van Helden PM, van den Berg HM, Gouw SC, Kaijen PH, Zuurveld MG, Mauser-Bunschoten EP, Aalberse RC, Vidarsson G, Voorberg J.
    Br J Haematol; 2008 Aug 25; 142(4):644-52. PubMed ID: 18510679
    [Abstract] [Full Text] [Related]

  • 9. Heterogeneity of the immune response to adenovirus-mediated factor VIII gene therapy in different inbred hemophilic mouse strains.
    Rawle FE, Shi CX, Brown B, McKinven A, Tinlin S, Graham FL, Hough C, Lillicrap D.
    J Gene Med; 2004 Dec 25; 6(12):1358-68. PubMed ID: 15493040
    [Abstract] [Full Text] [Related]

  • 10. Induction of human factor VIII inhibitors in rats by immunization with human recombinant factor VIII: a small animal model for humans with high responder inhibitor phenotype.
    Jarvis MA, Levin LG, Harrison JA, DePianto DJ, Suzuki CM, Ziaja CL, Brown JE, Jolly KW, Reisner HM, Abildgaard CF, Powell JS.
    Thromb Haemost; 1996 Feb 25; 75(2):318-25. PubMed ID: 8815584
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. von Willebrand factor and transforming growth factor-beta modulate immune response against coagulation factor VIII in FVIII-deficient mice.
    Kallas A, Kuuse S, Maimets T, Pooga M.
    Thromb Res; 2007 Feb 25; 120(6):911-9. PubMed ID: 17376515
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Von Willebrand factor modulates factor VIII immunogenicity: comparative study of different factor VIII concentrates in a haemophilia A mouse model.
    Behrmann M, Pasi J, Saint-Remy JM, Kotitschke R, Kloft M.
    Thromb Haemost; 2002 Aug 25; 88(2):221-9. PubMed ID: 12195693
    [Abstract] [Full Text] [Related]

  • 15. Humanized severe combined immunodeficient mice as a potential model for the study of tolerance to factor VIII.
    Vanzieleghem B, Gilles JG, Desqueper B, Vermylen J, Saint-Remy JM.
    Thromb Haemost; 2000 Jun 25; 83(6):833-9. PubMed ID: 10896234
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Immune response against serial infusion of factor VIII antigen through an implantable venous-access device system in haemophilia A mice.
    Madoiwa S, Kobayashi E, Kashiwakura Y, Sakata A, Yasumoto A, Ohmori T, Mimuro J, Sakata Y.
    Haemophilia; 2012 May 25; 18(3):e323-30. PubMed ID: 22044430
    [Abstract] [Full Text] [Related]

  • 18. An ELISA system to detect anti-factor VIII antibodies without interference by lupus anticoagulants. Preliminary data in hemophilia A patients.
    Blanco AN, Peirano AA, Grosso SH, Gennari LC, Bianco RP, Lazzari MA.
    Haematologica; 2000 Oct 25; 85(10):1045-50. PubMed ID: 11025595
    [Abstract] [Full Text] [Related]

  • 19. Adenovirus-mediated factor VIII gene expression results in attenuated anti-factor VIII-specific immunity in hemophilia A mice compared with factor VIII protein infusion.
    Bristol JA, Gallo-Penn A, Andrews J, Idamakanti N, Kaleko M, Connelly S.
    Hum Gene Ther; 2001 Sep 01; 12(13):1651-61. PubMed ID: 11535168
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.